Abstract-Numerous experimental studies suggest that oxidative stress contributes to the pathophysiology of hypertension and, importantly, that oxidative stress plays a more definitive role in mediating hypertension in males than in females. Intrauterine growth restriction induced by reduced uterine perfusion initiated at day 14 of gestation in the rat programs hypertension in adult male growth-restricted offspring; yet, female growth-restricted offspring are normotensive. The mechanisms mediating sex differences in blood pressure in adult growth-restricted offspring are not clear. Thus, this study tested the hypothesis that sex-specific differences in renal oxidative stress contribute to the regulation of blood pressure in adult growth-restricted offspring. A significant increase in blood pressure measured by telemetry in male growth-restricted offspring (PϽ0.05) was associated with a marked increase in renal markers of oxidative stress (PϽ0.05). Chronic treatment with the antioxidant Tempol had no effect on blood pressure in male control offspring, but it normalized blood pressure (PϽ0.05) and renal markers of oxidative stress (PϽ0.05) in male growth-restricted offspring relative to male control offspring. Renal markers of oxidative stress were not elevated in female growth-restricted offspring; however, renal activity of the antioxidant catalase was significantly elevated relative to female control offspring (PϽ0.05). Chronic treatment with Tempol did not significantly alter oxidative stress or blood pressure measured by telemetry in female offspring. Thus, these data suggest that sex differences in renal oxidative stress and antioxidant activity are present in adult growth-restricted offspring and that oxidative stress may play a more important role in modulating blood pressure in male but not female growth-restricted offspring. 1 Numerous studies indicate that growth restriction during late gestation is associated with the developmental programming of adult health and disease. 2,3 Barker et al 4 were the first to correlate adverse influences during fetal life with later cardiovascular risk, such as hypertension. Although numerous human and experimental studies address the theory of developmental programming of hypertension, 3,5 the exact mechanism(s) remains unclear. However, insight from experimental studies indicates that hypertension programmed in response to adverse influences during critical periods of early life may involve activation of the renal nerves, 6,7 the reninangiotensin system, 8,9 and oxidative stress. 10,11 Thus, developmental programming of adult cardiovascular risk may involve multiple regulatory system interactions on target organs.
I
ntrauterine growth restriction (IUGR) is a marker of impaired fetal growth and can result from a wide range of etiologic factors, including maternal conditions, placental insufficiency, and fetal genomic pathology. 1 Numerous studies indicate that growth restriction during late gestation is associated with the developmental programming of adult health and disease. 2, 3 Barker et al 4 were the first to correlate adverse influences during fetal life with later cardiovascular risk, such as hypertension. Although numerous human and experimental studies address the theory of developmental programming of hypertension, 3, 5 the exact mechanism(s) remains unclear. However, insight from experimental studies indicates that hypertension programmed in response to adverse influences during critical periods of early life may involve activation of the renal nerves, 6 ,7 the reninangiotensin system, 8, 9 and oxidative stress. 10, 11 Thus, developmental programming of adult cardiovascular risk may involve multiple regulatory system interactions on target organs.
Men have higher blood pressure and exhibit greater cardiovascular (CV) and renal risk than age-matched women before menopause. 12 Studies addressing sex differences in programmed CV and renal risk are limited, but many indicate that an inverse association between birth weight and blood pressure is present in both men and women. 13, 14 However, whether men and women differ in response to programmed CV and renal risk and whether age augments or attenuates this sex difference are not completely clear. Jones et al 15 report that smaller size at birth is associated with higher blood pressure in boys but not girls during childhood. Hallan et al 16 report that the effect of IUGR on renal function in young adulthood is weaker and less consistent in women compared with men. Jarvelin et al 14 report an inverse association between birth weight and systolic blood pressure for young adult men regardless of adjustment for body mass index; however, this inverse association is significant only in young adult women when adjusted for current body mass index. Andersson et al 17 report that size at birth, as a predictor of CV risk, is present in women at Ͼ60 years of age but not at 50 years of age. Thus, these studies indicate that human males exhibit greater programmed CV and renal risk compared with age-matched females, but the mechanisms responsible remain unknown.
Our laboratory uses a rat model of placental insufficiency that results in IUGR and sex differences in adult blood pressure. 18 Adult male growth-restricted offspring are hypertensive, whereas adult female growth-restricted offspring are normotensive. 18 Previous studies indicate that the renal nerves 7, 19 and the renin-angiotensin system 9 play a critical role in the etiology and maintenance of hypertension in male growth-restricted offspring. However, the exact mechanisms that mediate sex differences in adult blood pressure in this model of IUGR are not clear.
Numerous studies implicate oxidative stress in the development and maintenance of hypertension. [20] [21] [22] However, in many experimental models of hypertension, oxidative stress plays a more important role in the regulation of blood pressure in males than in females. 23 Several studies indicate that oxidative stress contributes to hypertension programmed by prenatal undernutrition, 10, 11 indicating a role for oxidative stress in the etiology of hypertension programmed by in utero insult. Many models of prenatally programmed hypertension exhibit sex differences in adult blood pressure 11, [24] [25] [26] [27] ; however, the exact mechanisms that mediate the sex difference in adult blood pressure in response to prenatal insult are not known. Thus, the goal of this study was to test the hypothesis that sex-specific differences in renal oxidative stress contribute to the regulation of blood pressure in adult growth-restricted offspring.
Methods

Animals
All of the experimental procedures were conducted in accordance with National Institutes of Health Guidelines for the Care and Use of Laboratory Animals with approval by the animal care and use committee at the University of Mississippi Medical Center. Timed pregnant Sprague-Dawley rats were purchased from Harlan Laboratories, Inc (Indianapolis, IN) and housed in a temperature-controlled room (23°C) with a 12:12-hour light/dark cycle with food and water available ad libitum. At day 14 of gestation, rats destined for reduced uterine perfusion underwent either a sham or reduced uterine perfusion procedure, as described below. All of the dams delivered at term (21-22 days of gestation) with birth weight recorded within 12 hours of delivery. Forty-eight hours after birth, offspring in each litter were culled to 8 pups per dam to ensure equal nutrient access for all of the offspring. Animal weights were recorded twice per week; pups were weaned at 3 weeks of age. Male and female offspring from 9 control pregnant and 9 reduced uterine perfusion pregnant litters were randomly assigned into 8 groups, male control untreated (vehicle or tap water), nϭ8; male IUGR untreated, nϭ8; male control treated (superoxide dismutase mimetic, Tempol), nϭ8; male IUGR treated, nϭ8; female control untreated, nϭ5; female IUGR untreated, nϭ5; female control treated, nϭ5; and female IUGR treated, nϭ5. To ensure diversity and that study of sex differences in oxidant status are the result of IUGR and not representative of a litter effect, only 1 male and 1 female offspring were selected per litter for study. All of the animals undergoing surgical procedures were anesthetized using 2% to 5% isoflurane by inhalation. All of the experimental end points were measured at 16 weeks of age to allow complete passage through puberty and into adulthood.
Reduced Uterine Perfusion in the Pregnant Rat
IUGR was induced by a reduction in uterine perfusion initiated at day 14 of gestation, as described previously. 18 Pregnant rats for production of control offspring underwent a sham procedure. For more detail, see the online-only Data Supplement.
Chronic Administration of the Superoxide Dismutase Mimetic Tempol
Tempol was administered by drinking water (1 mmol/L) for 2 weeks starting at 14 weeks of age using a dose reported as effective to reduce oxidative status. 28 Untreated animals received vehicle (tap water ad libitum). Drinking water was measured daily during the treatment period in all of the animals.
Mean Arterial Pressure in Conscious Offspring
Mean arterial pressure (MAP) was measured continuously in conscious, free-moving offspring using radiotelemetry (Data Sciences International, Minneapolis, MN), as described previously. 9 For more detail, see the online-only Data Supplement.
Superoxide Anion Production Measurement
To determine basal and NADPH-stimulated renal and superoxide production in male and female rats, basal and NADPH-stimulated renal and superoxide production was measured using lucigenin chemiluminescence in the presence (NADPH stimulated) or absence (basal) of 0.1 mmol/L of NADPH. Briefly, renal basal superoxide anion production was measured via the lucigenin chemiluminescence method, as described previously by Park et al. 21 For more detail, see the online-only Data Supplement.
F 2 -Isoprostanes
Twenty-four-hour urinary excretion of F 2 -isoprostanes was measured according to a modified version of the procedure by Dobrian et al 22 with a competitive ELISA (Oxford Biomedical Research), as described previously, 29 with values normalized to urinary creatinine levels (CR 01, Oxford Biomedical Research).
Renal Antioxidant Enzyme Protein Expression
Kidneys were flash frozen and stored at Ϫ80°C until use. Frozen tissue was homogenized in radioimmunoprecipitation assay buffer containing a protease inhibitor mixture (Roche Pharmaceuticals). Protein concentration was determined using Pierce BCA Protein Assay (Pierce). Protein lysates were subjected to SDS-PAGE, transferred onto polyvinylidene fluoride membranes, and blocked with Odyssey Brand blocking buffer. Membranes were incubated with antibodies overnight, including anti-catalase (CAT), anti-manganese superoxide dismutase (SOD), anti-Cu/Zn SOD, anti-glutathione peroxidase (GPX; Meridian Life Science), and anti-␣-tubulin (Neomarkers). Membranes were probed with the appropriate infrared dye secondary antibodies with bands visualized with an Odyssey infrared imaging system and quantification performed using the QuantOne software. All of the samples were run in triplicate.
Renal CAT, GPX, and SOD Activity Assays
Renal CAT, GPX, and SOD activities in whole kidney tissue were analyzed according to manufacturer directions (Cayman Chemical Company). Activity data were normalized to protein concentration (protein assay kit, Pierce Product). For more detail, see the onlineonly Data Supplement.
Statistics
Graphpad PRISM version 5 and IBM R SPSS Statistics version 19 were used for all of the statistical analysis. Comparisons made between groups used ANOVA with adjustment for multiple comparisons. Bonferroni post hoc test was used for multiple comparisons. The general linear model (SPSS) univariate with 3-way interactions (3-way ANOVA) was used to calculate interactions related to birth weight, sex, and treatment. Statistical significance of the interaction was set with PϽ0.05 and F values Ͼ5. The sample sizes for all of the experiments were calculated to attain a statistical power of Ն0.85. compared with control offspring from control or sham dams (Table) . At 16 weeks of age, body weight did not differ on comparison of same-sex growth-restricted offspring to samesex control offspring (Table) . However, male offspring were heavier relative to counterpart female offspring within control and growth-restricted groups (Table) . Water consumption did not differ between animals receiving vehicle (tap water) relative to animals receiving Tempol (Table) .
Mean Arterial Pressure
As reported previously, IUGR leads to a marked increase in MAP at 16 weeks of age in adult male growth-restricted offspring (PϽ0.05) relative to control offspring that is not observed in adult female growth-restricted offspring ( Figure S1 , available in the online-only Data Supplement). Chronic treatment with the antioxidant Tempol had no effect on MAP in male control offspring ( Figure 1 ). However, chronic treatment with Tempol significantly reduced MAP in male growth-restricted offspring (PϽ0.05), normalizing blood pressure in Tempoltreated male growth-restricted offspring to levels comparable to untreated male control offspring ( Figure 1 ). MAP was not significantly different between adult female control and adult female growth-restricted offspring in the untreated group; moreover, chronic treatment with the antioxidant Tempol did not significantly alter blood pressure in female offspring, control, or growth-restricted offspring ( Figure 2 ).
Renal Markers of Oxidative Stress
Twenty-four-hour urinary excretion of F 2 -isoprostanes was significantly elevated in untreated male growth-restricted offspring compared with untreated male controls (PϽ0.05; Figure  3A ). Chronic treatment with Tempol significantly reduced urinary F 2 -isoprostanes in male growth-restricted offspring (PϽ0.05) but had no significant effect in male controls ( Figure 3A ). Urinary excretion of F 2 -isoprostanes did not differ on comparison of untreated female control and untreated female growth-restricted offspring; chronic treatment with Tempol did not alter F 2 -isoprostane levels in female control or female growth-restricted offspring ( Figure 3A) . However, urinary excretion of F 2 -isoprostanes was significantly elevated in untreated male growth-restricted offspring relative to untreated female growth-restricted offspring (PϽ0.05; Figure 3A) .
Renal basal superoxide anion production was significantly elevated in untreated male growth-restricted offspring as compared with untreated male controls (PϽ0.05; Figure 3B ). Chronic treatment with Tempol significantly decreased renal basal superoxide anion production in male growth-restricted offspring (PϽ0.05) with no effect in male controls (Figure 3B). Renal basal superoxide anion production did not differ on comparison of female control and female growthrestricted offspring in the untreated group or after chronic treatment with Tempol ( Figure 3B ). However, basal superoxide anion production within the kidney was significantly elevated in male growth-restricted offspring compared with female growth-restricted offspring (PϽ0.05; Figure 3B ).
Renal NADPH oxidase-dependent superoxide anion production was significantly elevated in untreated male growthrestricted offspring compared with untreated male controls (PϽ0.05); no difference was observed in untreated female growth-restricted offspring relative to untreated female controls; yet, it was significantly elevated in untreated male growth-restricted offspring compared with untreated female growth-restricted offspring (PϽ0.05; Figure 3C ). Chronic treatment with Tempol significantly decreased renal NADPH oxidase-dependent superoxide production in male growthrestricted offspring relative to its untreated counterpart (PϽ0.05); however, it had no effect in male control, female control, or female growth-restricted offspring relative to their untreated counterparts ( Figure 3C ).
Renal Antioxidant Enzyme Protein Expression
Renal protein expression of antioxidant enzymes CAT, GPX, manganese SOD, and copper/zinc SOD (Cu-Zn-SOD) did not differ on comparison of male growth-restricted offspring relative to male control in the untreated group ( Figure 5 ). Tempol significantly increased renal CAT and GPX protein expression in male growth-restricted offspring relative to untreated counterparts (PϽ0.05; Figure 4) . In female offspring, renal expression of the antioxidant enzymes CAT and GPX were significantly elevated in untreated growth-restricted offspring relative to untreated control (PϽ0.05; Figure 5 ). Chronic treatment with Tempol significantly reduced renal CAT and GPX protein expression in female growth-restricted offspring compared with their untreated counterparts (PϽ0.05; Figure  5 ). Renal expression of Cu-Zn-SOD and manganese-SOD did not differ on comparison of female control or growthrestricted offspring, treated or untreated.
Renal Antioxidant Enzyme Activity
Activity of renal antioxidant enzymes CAT, GPX, and Cu-Zn-SOD did not differ on comparison of male growth-restricted offspring relative to male controls in the untreated group ( Figure  6 ). Chronic treatment with the antioxidant Tempol significantly increased activity of renal CAT enzyme in male growth-restricted offspring relative to its untreated counterpart (PϽ0.05; Figure 6 ). Activity of the renal manganese-SOD enzyme was not measured because of technical difficulties with the assay. In female offspring, activity of renal CAT activity was significantly elevated in untreated growthrestricted offspring relative to untreated controls (PϽ0.05; Figure 6 ). Chronic treatment with Tempol significantly reduced activity of the renal CAT enzyme in female growthrestricted offspring relative to treated female controls and untreated female growth-restricted (PϽ0.05; Figure 6 ). Activity of renal GPX and Cu-Zn-SOD did not differ on comparison of female control or female growth-restricted offspring, treated or untreated. The general linear model (IBM R SPSS) with 3-way interaction showed statistically significant effects of treatment (PϽ0.03; Fϭ5.17) and sex (PϽ0.02; Fϭ5.88) for CAT enzyme activity and an effect of sex (PϽ0.000 Fϭ41.00) for GPX enzyme activity in growthrestricted offspring. No effects were observed for Cu-Zn-SOD enzyme activity.
Heart Rate
Heart rate (HR) averaged for a 24-hour period at 16 weeks of age was significantly elevated in adult male growthrestricted offspring compared with adult male control offspring (PϽ0.05; Figure 7) . HR was significant elevated in adult female offspring compared with age-matched male control and growth-restricted offspring (PϽ0.05; Figure 7 ). Chronic treatment with the antioxidant Tempol significantly reduced HR in adult male growth-restricted offspring (PϽ0.05), normalizing it relative to untreated male control offspring; chronic Tempol had no effect on HR in control male, female control, or female growth-restricted offspring (Figure 7 ).
Discussion
The major findings from this study are described here. First, hypertensive male growth-restricted offspring exhibited a marked increase in renal markers of oxidative stress compared with normotensive male control offspring. Second, chronic treatment with the SOD mimetic Tempol normalized blood pressure in male growth-restricted offspring relative to male control and, third, renal markers of oxidative stress in male growth-restricted offspring relative to untreated male animals. Fourth, hypertensive male growth-restricted offspring exhibited a marked increase in renal markers of oxidative stress compared with normotensive female control and growth-restricted offspring. Fifth, renal markers of oxidative stress did not differ on comparison of normotensive female growth-restricted offspring to normotensive female control offspring. Sixth, and importantly, a significant increase in renal CAT protein expression and activity was observed in female growth-restricted offspring compared with female control. Thus, these findings suggest that sex differences in renal markers of oxidative stress are present in adult growth-restricted offspring and that oxidative stress may play a more important role in modulating blood pressure in male but not female growth-restricted offspring. Furthermore, upregulation of renal CAT in female growth-restricted offspring may serve as a counterregulatory mechanism against the increase in renal superoxide production and hypertension programmed by in utero insult.
Experimental models of hypertension, such as obesityinduced, deoxycorticosterone acetate salt and the spontaneously hypertensive rat indicate a link between increased oxidative stress and hypertension. [20] [21] [22] 30, 31 However, recent studies indicate that oxidative stress may have differential effects on blood pressure in males versus females in experimental models of hypertension. 23 Sex differences in adult CV risk are observed in models of developmental programming of hypertension induced via prenatal protein restriction, uteroplacental insufficiency, and fetal glucocorticoid exposure. 11, [24] [25] [26] [27] Furthermore, marked increases in markers of oxidative stress are observed in experimental models of hypertension programmed by in utero insult. 10, 11 However, whether sex differences in oxidative stress and antioxidant capacity contribute to the sex-specific programming of hypertension in these models of in utero insult is not clear. Previously, we noted a key role for testosterone in mediating hypertension in adult male growth-restricted offspring. 9 Plasma levels of testosterone are elevated 2-fold in adult male growth-restricted offspring relative to control offspring and castration abolishes hypertension in adult male growth-restricted offspring. 9 Testosterone induces oxidative stress in the male spontaneously hypertensive rat. 32, 33 Furthermore, male sponta- neously hypertensive rats exhibit higher levels of oxidative stress in microvessels as compared with female spontaneously hypertensive rats. 34 In the current study, only male growth-restricted offspring exhibited an increase in renal production of superoxide and urinary excretion of F 2 -isoprostanes. Thus, the increase in renal superoxide production and urinary excretion of F 2 -isoprostanes in adult male growth-restricted offspring may be mediated via increased plasma levels of testosterone programmed by IUGR.
We reported previously that male and female growthrestricted offspring develop hypertension as early as 4 to 6 weeks of age 18 and that female growth-restricted offspring become normotensive after puberty. 18 Ovariectomy induces hypertension in adult female growth-restricted offspring, whereas estrogen replacement reverses this effect, indicating that estrogen is protective against hypertension programmed by IUGR in adult female growth-restricted offspring. 35 Numerous studies indicate that estrogen exhibits antioxidant properties. [36] [37] [38] Activity of the antioxidant enzyme CAT is strongly regulated by estrogen in female rats; furthermore, total SOD activity is greater in females rats compared with males. 39 GPX is increased by estrogen treatment in female rats 40 and in humans; serum GPX levels and activity are higher in women compared with men. 41 In the current study, renal protein expressions of CAT and GPX were significantly increased in female growthrestricted offspring relative to female control. Importantly, female growth-restricted offspring exhibited a significant increase in renal CAT activity relative to female control. Increased reactive oxygen species (ROS) production and hypertension in angiotensinogen transgenic mice are prevented by overexpression of CAT. 42 Therefore, compensatory upregulation of antioxidant capacity may contribute to normalization of blood pressure in adult female growth-restricted offspring and contribute to sex differences in hypertension programmed in response to IUGR. Furthermore, upregulation of antioxidant capacity by estrogen may be one mechanism by which estrogen is protective against hypertension induced by IUGR in adult female growthrestricted rats. The exact mechanisms by which ROS contribute to elevations in blood pressure are not clear. Experimental studies indicate that ROS may increase blood pressure via activation of the sympathetic nervous system. [43] [44] [45] [46] Whether ROS activate peripheral sympathetic nervous system activity 46 or peripheral and central sympathetic nervous system activity is not clear. 43 Moreover, the acute actions of systemic Tempol to reduce blood pressure in several experimental models of hypertension are associated with a reduction in renal sympathetic nerve activity [43] [44] [45] [46] that occurs in the absence of a reduction in vascular superoxide production. 44 Thus, the mechanism by which Tempol reduces blood pressure acutely may involve different sites and mechanisms of action that may be specific to the experimental model. The marked increase in blood pressure and HR in male growth-restricted offspring was normalized relative to male control offspring by chronic treatment with Tempol. In addition, the reduction in blood pressure after chronic treatment with Tempol was associated with a marked reduction in renal superoxide production, suggesting that the drop in blood pressure in male growth-restricted offspring is associated with a decrease in ROS within the kidney. However, the antihypertensive effect of Tempol on male growth-restricted offspring in this study may also be attributed to influences mediated via the sympathetic nervous system. The renal nerves play a key role in hypertension induced by IUGR in male growth-restricted offspring. 7, 19 Thus, further studies will determine whether the reduction in MAP in male growth-restricted offspring after chronic treatment with Tempol involves direct inhibition of sympathetic nerve activity. In addition, further studies may be needed to determine whether the mechanism by which chronic treatment with Tempol leads to a reduction in MAP in male growth-restricted offspring involves downregulation of inflammation. 47, 48 Adult male growth-restricted offspring exhibit a marked increase in circulating inflammatory cytokines indicative of chronic inflammation. 49 Thus, the mechanisms by which the antioxidant Tempol acts to reduce blood pressure may be complex and multifactorial.
In conclusion, hypertension in adult male growth-restricted offspring was associated with a marked increase in renal markers of oxidative stress. Female growth-restricted offspring did not demonstrate an increase in renal markers of oxidative stress. Chronic treatment with the antioxidant Tempol abolished hypertension and reduced renal markers of oxidative stress in adult male growth-restricted offspring. Female growth-restricted offspring showed elevated renal CAT activity. Thus, data from this study suggest that IUGR induced by placental insufficiency programs an increase in renal oxidative stress that contributes to the etiology of hypertension in male growth-restricted offspring. Testosterone may exacerbate renal superoxide production, whereas estrogen may counteract the increase in renal superoxide production via upregulation of key antioxidant enzymes. Therefore, sex-specific programming of renal superoxide production and antioxidant capacity may contribute to sex differences in hypertension programmed by IUGR. 
What Is Relevant?
• Numerous experimental models of hypertension report that oxidative stress plays a more important role in blood pressure regulation in males compared with females. Thus, oxidative stress may be one mechanism that contributes to sex differences in adult blood pressure in models of prenatal programmed hypertension.
Summary
Thus, this study indicates that sex-specific programming of renal oxidative stress contributes to sex differences in the developmental programming of adult blood pressure in growth-restricted offspring. Insight from this study highlights the sex-specific programming of oxidant status in male growth-restricted offspring relative to female growth-restricted offspring.
